360° SearchNetwork Hot Spots Trends Time Series

Aredia

Type: Keyphrase

Name: Aredia

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Improper Substitute Plaintiffs May Lead To Dismissal Of 2 Aredia/Zometa Cases

NASHVILLE - A Tennessee federal magistrate judge in the Aredia/Zometa multidistrict litigation on May 3 recommended that a plaintiff and his attorney be sanctioned with dismissal of their case with prejudice after finding that the attorney willfully failed ... [Published Mealey - May 07 2013]

Entities: Aredia, Zometa, Dismissal, Litigation, With Prejudice

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Achieving metabolic goals possible in critical care population

PHOENIX — Researchers at the Mount Sinai Hospital respiratory care unit were able to optimize glycemic control safely among patients with acute critical illness requiring prolonged mechanical ventilation and tracheotomy, according to data presented here ... [Published Endocrine Today - May 07 2013]

Entities: Patient, hypoglycemia, Nutrition

First reported Apr 27 2013 - Updated Apr 28 2013 - 1 reports

Novartis AG

Novartis Treated Doctors to Fishing, Hooters Outings, U.S. Says

Novartis AG (NOVN) was sued by the U.S., for the second time this week, for allegedly paying kickbacks to increase prescription-drug sales.Novartis plied physicians with expensive dinners, speaker fees, fishing trips and outings at Hooters restaurants ... [Published Bloomberg - Apr 27 2013]

Entities: Novartis AG, Hooters, Drugs

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Pharmaceutical Warning! Delaware Workers’ Compensation Benefits

Heather A. Long, Esq.Many of us, especially women, can remember the catchy tune in the birth control commercial where the ladies are clad in 50’s style bathing suits and caps and execute synchronized dives into a pool of water. (Monday, Tuesday, Wednesday, ... [Published County Women's Journal - Apr 23 2013]

Entities: Drugs, Workers, Femur

First reported Apr 15 2013 - Updated Apr 15 2013 - 1 reports

Aredia/Zometa Produces an Opinion on the Learned Intermediary Doctrine, Comment k, and Warranty Claims

The Aredia/Zometa case of Guenther v. Novartis Pharmaceuticals Inc. , 2013 U.S. Dist. LEXIS 50945 (M.D. Fl. Apr. 9, 2013), produced another interesting decision last week. Not necessarily good, but interesting. The defense moved for summary judgment ... [Published Drug and Device Law - Apr 15 2013]

Entities: Zometa, Aredia, Testimony, Drugs, Novartis AG

First reported Apr 10 2013 - Updated Apr 10 2013 - 1 reports

Roger Ebert

Thumbs Down on Dopson-Troutt Aredia/Zometa Case

The geezers in our family have been busy recently ululating over the rule of three celebrity deaths. We are not sure we have ever before witnessed a trilogy quite like Roger Ebert, Margaret Thatcher, and Annette Funicello. An aunt insists that it is ... [Published Drug and Device Law - Apr 10 2013]

Entities: Roger Ebert, Zometa, Aredia

First reported Apr 05 2013 - Updated Apr 05 2013 - 1 reports

That Was The Week That Was

A lot of things happened last week – so much that our usual wrap-up search last Friday took over three hours, which is more than twice as long as normal. Since there were too many cases of interest to blog about separately, we’re doing the next best ... [Published Drug and Device Law - Apr 05 2013]

Entities: Aredia, Zometa, Liability, Hearsay

First reported Mar 15 2013 - Updated Mar 15 2013 - 1 reports

Another Choice of Law Win on Punitive Damages

In a departure from blog tradition (and possibly etiquette), I’m going to break the fourth wall and speak in the first-person singular for a moment. After much encouragement from my colleagues and several not-so-subtle hints from Bexis directed at having ... [Published Drug and Device Law - Mar 15 2013]

Entities: Punitive Damages, Aredia, Zometa, New Jersey Legislature, Actual Damages

First reported Mar 12 2013 - Updated Mar 12 2013 - 1 reports

Consolidation Fails In Aredia/Zometa

We’ve blogged several times in opposition to consolidation of individual plaintiffs’ lawsuits in product liability actions. The only thing that plaintiffs seeking consolidation for trial have in common is that: (1) they were allegedly injured ... [Published Drug and Device Law - Mar 12 2013]

Entities: Aredia, Zometa, Novartis AG, Drugs, Liability

First reported Feb 22 2013 - Updated Feb 22 2013 - 1 reports

A One-Two Punch in the Aredia/Zometa Litigation

Here's another quasi-guest post from our quasi-regular blogger - Reed Smith's Melissa Wojtylak. It's her post, I'm just the piano player.****************** Novartis scored a double victory in the Northern District of California last week, when the court ... [Published Drug and Device Law - Feb 22 2013]

Entities: Aredia, Zometa, Plaintiff

First reported Feb 15 2013 - Updated Feb 15 2013 - 1 reports

The Latest On Aredia/Zometa

With both sides lobbing us cases (yes the PR war over Aredia/Zometa has heated up to the point that even plaintiffs send us stuff) in the ongoing Aredia/Zometa (hereafter "A/Z" - for obvious reasons) product liability struggle, we know of four new decisions. ... [Published Drug and Device Law - Feb 15 2013]

Entities: Punitive Damages, Aredia, Zometa

First reported Jan 15 2013 - Updated Jan 15 2013 - 1 reports

Atypical Femur Fractures: Due To Fosamax Or A Bisphosphonates Drug Class Side Effect?

The Fact That Fosamax Has Been Most Prescribed More Often Than Actonel, Aredia, Boniva, Etc., May Blur The Answer To This Drug-Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com ) In June 2012 the (then) Archives of Internal Medicine published ... [Published Drug Injury Watch - Jan 15 2013]

Entities: Bisphosphonates, Fosamax, Femur, Boniva

Quotes

Wilson, 2013 WL 593895, at *10 ( "[m]ost of their arguments in support of that motion simply are not on point, and appear to be designed more to mislead than to provide rational argument directed to the true reasons why those rulings were made" ). Second, the motion to dismiss was granted – but on the merits, not for lack of jurisdiction

When An Opinion Starts Out This Way…. [Published Drug and Device Law - Mar 07 2013]

...From the Editor's Correspondence section, we start with "Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?" , which makes the inquiry whether the authors of that June 2012 bisphosphonate femoral fracture study article failed to distinguish between the increased...

Atypical Femur Fractures: Due To Fosamax Or A Bisphosphonates Drug Class Side Effect? [Published Drug Injury Watch - Jan 15 2013]

More Content

sort by: Date \| Relevance
While We’re Waiting on Bartlett, Some New Preem... [Published FDA Law Blog - May 20 2013]
Improper Substitute Plaintiffs May Lead To Dism... [Published Mealey - May 07 2013]
Achieving metabolic goals possible in critical ... [Published Endocrine Today - May 07 2013]
Novartis Treated Doctors to Fishing, Hooters Ou... [Published Bloomberg - Apr 27 2013]
MDL Precedent Rescue - Big List [Published Drug and Device Law - Apr 25 2013]
Pharmaceutical Warning! Delaware Workers’ Compe... [Published County Women's Journal - Apr 23 2013]
Aredia/Zometa Produces an Opinion on the Learne... [Published Drug and Device Law - Apr 15 2013]
Thumbs Down on Dopson-Troutt Aredia/Zometa Case [Published Drug and Device Law - Apr 10 2013]
That Was The Week That Was [Published Drug and Device Law - Apr 05 2013]
Another Choice of Law Win on Punitive Damages [Published Drug and Device Law - Mar 15 2013]
Consolidation Fails In Aredia/Zometa [Published Drug and Device Law - Mar 12 2013]
When An Opinion Starts Out This Way…. [Published Drug and Device Law - Mar 07 2013]
A One-Two Punch in the Aredia/Zometa Litigation [Published Drug and Device Law - Feb 22 2013]
The Latest On Aredia/Zometa [Published Drug and Device Law - Feb 15 2013]
Atypical Femur Fractures: Due To Fosamax Or A B... [Published Drug Injury Watch - Jan 15 2013]
Our Favorites - The Best Prescription Drug/Medi... [Published Drug and Device Law - Dec 28 2012]
What We Like To See From A To Z [Published Drug and Device Law - Dec 20 2012]
P2K and Dr. Parisian [Published Drug and Device Law - Dec 17 2012]

Blogs

sort by: Date \| Relevance
While We’re Waiting on Bartlett, Some New Preem... [Published FDA Law Blog - May 20 2013] By Kurt R. Karst –As folks in the generic drug industry patiently await the U.S. Supreme Court’s decision in Mutual Pharmaceutical Co. v. Bartlett (Docket No. 12-142), a design defect generic drug preemption case (see our previous post here), we thought ...
MDL Precedent Rescue - Big List [Published Drug and Device Law - Apr 25 2013] Several of us (the Reed Smith side, obviously) recently attended the firm partners’ retreat. All our brainstorming about how to improve client service. In some ways, legal blogging’s not that much different than other legal services– we just don’t get ...
Aredia/Zometa Produces an Opinion on the Learne... [Published Drug and Device Law - Apr 15 2013] The Aredia/Zometa case of Guenther v. Novartis Pharmaceuticals Inc. , 2013 U.S. Dist. LEXIS 50945 (M.D. Fl. Apr. 9, 2013), produced another interesting decision last week. Not necessarily good, but interesting. The defense moved for summary judgment ...
Thumbs Down on Dopson-Troutt Aredia/Zometa Case [Published Drug and Device Law - Apr 10 2013] The geezers in our family have been busy recently ululating over the rule of three celebrity deaths. We are not sure we have ever before witnessed a trilogy quite like Roger Ebert, Margaret Thatcher, and Annette Funicello. An aunt insists that it is ...
That Was The Week That Was [Published Drug and Device Law - Apr 05 2013] A lot of things happened last week – so much that our usual wrap-up search last Friday took over three hours, which is more than twice as long as normal. Since there were too many cases of interest to blog about separately, we’re doing the next best ...